Levothyroxine Sodium
- Product NDC
- 25021-468
- 11-digit product format
- 250210468
- Labeler code
- 25021
- Product ID
- 25021-468_2662e418-ef9b-40be-abbd-db71401e3c20
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium Anhydrous
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA208749
- Marketing category
- ANDA
- Marketing start
- 2024-01-01
- Substance
- LEVOTHYROXINE SODIUM ANHYDROUS
- Active strength
- 100 ug/5mL
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 054I36CPMN | LEVOTHYROXINE SODIUM ANHYDROUS | 55-03-8 | LEVOTHYROXINE SODIUM ANHYDROUS |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 25021-468-10 | 25021046810 | 1 VIAL in 1 CARTON (25021-468-10) / 5 mL in 1 VIAL | 1 vial | 2024-01-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Levothyroxine Sodium | Sagent Pharmaceuticals | 2023-10-19 | HUMAN PRESCRIPTION DRUG LABEL | 1 |